-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DntAZ8JXfgONYeXP2/DoK/h2w+gZBYsNQXskPsGeQ4PXvdBQmun6Z54YSN0JyN9S rkMTxDWf+QLpp356F51uzA== 0001193125-04-084736.txt : 20040511 0001193125-04-084736.hdr.sgml : 20040511 20040511162009 ACCESSION NUMBER: 0001193125-04-084736 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040510 ITEM INFORMATION: FILED AS OF DATE: 20040511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MANNATECH INC CENTRAL INDEX KEY: 0001056358 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 752508900 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-24657 FILM NUMBER: 04796646 BUSINESS ADDRESS: STREET 1: 600 SOUTH ROYAL LANE STREET 2: SUITE 200 CITY: COPPELL STATE: TX ZIP: 75019 BUSINESS PHONE: 9724717400 MAIL ADDRESS: STREET 1: 600 SOUTH ROYAL LANE STREET 2: SUITE 200 CITY: COPPELL STATE: TX ZIP: 75019 8-K 1 d8k.htm FORM 8-K Form 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): May 10, 2004

 


 

MANNATECH, INCORPORATED

(Exact Name of Registrant as Specified in its Charter)

 

Texas   000-24657   75-2508900

(State or other Jurisdiction of

Incorporation or Organization)

  (Commission File Number)   (I.R.S. Employer Identification No.)

 

600 S. Royal Lane, Suite 200

Coppell, Texas 75019

(Address of Principal Executive Offices, including Zip Code)

 

Registrant’s Telephone Number, including Area Code: (972) 471-7400

 



Item 12. Results of Operations and Financial Condition

 

On May 10, 2004, Mannatech, Incorporated, a Texas corporation, issued a press release announcing its financial and operating results for the first quarter ended March 31, 2004. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.


SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

     MANNATECH, INCORPORATED
      

Dated: May 11, 2004

  

/s/ Stephen D. Fenstermacher

    
    

Name: Stephen D. Fenstermacher

    

Title: Chief Financial Officer

 


EXHIBIT INDEX

 

Exhibit
Number


  

Exhibit


99.1*    Press release dated May 10, 2004 entitled “Mannatech Reports Continued Growth in Revenues.”

*Filed herewith.

EX-99.1 2 dex991.htm PRESS RELEASE DATED MAY 10, 2004 Press Release dated May 10, 2004

Exhibit 99.1

 

Mannatech Reports Continued Growth in Revenues

The Company continues to report an increase in revenues.

 

Coppell, Texas – May 10, 2004 – Mannatech, Incorporated (NASDAQ: MTEX) announced its consolidated net sales, net income, and diluted earnings per share for the three months ended March 31, 2004 were $58.4 million, $3.1 million, and $0.11 per share, respectively. Compared to the same period in 2003, sales increased $17.9 million, or 44.3%, net income increased $1.7 million, or 118.8%, which more than doubled; and diluted earnings per share increased $0.05, for an increase of 83.3%. Quarterly sales for the first quarter of 2004 for the international developer of nutritional supplements, topical products and weight management products was $58.4 million, which set a new quarterly sales record and surpassed its previous best quarterly sales record by $4.1 million, or 7.6%. Mannatech largely attributes its increase in revenues and earnings per share to the continued increase in building momentum from both new and existing associates and members. Net sales by country for the three months ended March 31, in millions, and as a percentage of net sales are as follows:

 

     United States

  Canada

  Australia

  United
Kingdom


  Japan

  New
Zealand


  Total

2004

   $36.8  63.0%   $4.7  8.0%   $6.5  11.1%   $2.8  4.8%   $5.0  8.6%   $2.6  4.5%   $58.4  100%

2003

   $28.0  69.1%   $3.9  9.6%   $2.6    6.4%   $0.6  1.5%   $4.0  9.9%   $1.4  3.5%   $40.5  100%

% increase 2004 over 2003

   31.4%   20.5%   150.0%   366.7%   25.0%   85.7%   44.3%

 

Mannatech also attributed its improved financial performance to its ability to control its operating expenses and the September 2003 launch of its new antioxidant product in the United States and Canada, called Ambrotose AO.

 

Samuel L. Caster, Mannatech’s Chairman and Chief Executive Officer stated, “Once again Mannatech broke its highest sales record for any one quarter and we are enthusiastic about the remainder of 2004, as historically our first quarter is the lowest sales quarter of the calendar year. In addition, attendance at Mannafest, our annual corporate-sponsored event held each March, almost doubled in 2004 as compared to the attendance at our annual event in 2003. We believe our steady growth and profitability has built a strong and solid foundation, which will be further strengthened by our planned international launch into South Korea in the third quarter of 2004 and planned entry into Taiwan in the first quarter of 2005, coupled with our planned rollout of our newest product, Ambrotose AO, this year into the United Kingdom, Japan, Australia, and New Zealand.”

 

Mr. Caster also stated “We continue to be encouraged by the sales efforts from our independent associates, whose activity brought 141,000 new consumers to Mannatech for the twelve-months ended March 31, 2004 compared to 100,000 new consumers for the same period in 2003. We remain fully committed to pledging our support to our customers, independent associates, and to our shareholders as we believe in our products, our company, our people, and our future.”

 

The number of new and continuing Mannatech independent associates and members who purchased Mannatech’s products within the last 12 months is as follows:

 

     For the twelve months ended March 31,

 
     2003

    2004

 

New

   100,000    47.2 %   141,000    49.1 %

Continuing

   112,000    52.8 %   146,000    50.9 %
    
  

 
  

Total

   212,000    100.0 %   287,000    100.0 %
    
  

 
  


About Mannatech, Incorporated

 

Mannatech, based in Coppell, Texas, is a wellness solution provider that sells its products through a global network-marketing system throughout the United States and the international markets of Canada, Australia, the United Kingdom, Japan and New Zealand. For additional information about Mannatech, please visit its corporate website: www.mannatech.com.

 

Please Note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “may,”“attributes,” “continues to be encouraged,” “believes,” and “plans” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that its expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions its readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

 

(Unaudited financial schedules to follow)

 

Contact:

Mannatech, Incorporated

Stephen Fenstermacher

972-471-6512

IR@mannatech.com


MANNATECH, INCORPORATED

CONSOLIDATED BALANCE SHEETS—UNAUDITED

(in thousands, except share amounts)

 

     December 31,
2003


    March 31,
2004


 

ASSETS

                

Cash and cash equivalents

   $ 28,291     $ 26,774  

Restricted cash

     2,140       392  

Investments

     —         2,146  

Accounts receivable

     134       398  

Current portion of notes receivable from shareholders

     55       —    

Inventories

     7,861       9,034  

Prepaid expenses and other current assets

     2,084       2,560  

Deferred tax assets

     2,363       2,368  
    


 


Total current assets

     42,928       43,672  

Property and equipment, net

     5,514       5,278  

Long-term investments

     9,994       13,006  

Notes receivable from shareholders, excluding current portion

     150       152  

Deferred tax assets

     631       645  

Restricted cash

     —         211  

Other assets

     806       600  
    


 


Total assets

   $ 60,023     $ 63,564  
    


 


LIABILITIES AND SHAREHOLDERS’ EQUITY

                

Current portion of capital leases and notes payable

   $ 16     $ 12  

Accounts payable

     2,687       2,263  

Accrued expenses

     19,940       21,171  

Deferred revenue

     3,142       5,037  

Current portion of accrued severance related to former executives

     953       731  
    


 


Total current liabilities

     26,738       29,214  

Capital leases and notes payable, excluding current portion

     32       34  

Accrued severance related to former executives, excluding current portion

     359       272  

Long-term liabilities

     106       245  

Deferred tax liabilities

     —         13  
    


 


Total liabilities

     27,235       29,778  
    


 


Commitments and contingencies

     —         —    

Shareholders’ equity:

                

Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued and outstanding

     —         —    

Common stock, $0.0001 par value, 99,000,000 shares authorized, 26,227,171 shares issued and 26,183,422 outstanding in 2003 and 26,399,505 shares issued and 26,325,190 outstanding in 2004

     3       3  

Additional paid-in capital

     24,175       24,848  

Retained earnings

     9,271       9,752  

Accumulated other comprehensive loss

     (422 )     (255 )
    


 


       33,027       34,348  
    


 


Less treasury stock, at cost, 43,749 shares in 2003 and 74,315 in 2004

     (239 )     (562 )
    


 


Total shareholders’ equity

     32,788       33,786  
    


 


Total liabilities and shareholders’ equity

   $ 60,023     $ 63,564  
    


 



MANNATECH, INCORPORATED

CONSOLIDATED STATEMENTS OF OPERATIONS—UNAUDITED

(in thousands, except per share information)

 

     For the three months
ended March 31,


 
     2003

    2004

 

Net sales

   $ 40,470     $ 58,386  

Cost of sales

     6,697       8,657  

Commissions and incentives

     16,341       25,866  
    


 


       23,038       34,523  
    


 


Gross profit

     17,432       23,863  

Operating expenses:

                

Selling and administrative expenses

     9,830       12,305  

Other operating costs

     5,725       6,984  
    


 


Total operating expenses

     15,555       19,289  
    


 


Income from operations

     1,877       4,574  

Interest income

     76       138  

Interest expense

     (2 )     —    

Other income (expense), net

     112       (93 )
    


 


Income before income taxes

     2,063       4,619  

Income tax expense

     (644 )     (1,514 )
    


 


Net income

   $ 1,419     $ 3,105  
    


 


Earnings per common share:

                

Basic

   $ 0.06     $ 0.12  
    


 


Diluted

   $ 0.06     $ 0.11  
    


 


Weighted-average common shares outstanding:

                

Basic

     25,135       26,279  
    


 


Diluted

     25,251       27,414  
    


 


-----END PRIVACY-ENHANCED MESSAGE-----